MedTech and pharmaceutical companies acquiring AI capabilities through marketplace vendors are solving an access problem while creating a structural dependency. This white paper argues that vertical integration of AI infrastructure, owning the data architecture, model development environment, validation and compliance layer, and deployment stack, produces durable competitive advantages that marketplace dependency cannot. The evidence is now concrete enough to act on. The window for making this investment at reasonable cost is narrowing.